Mark Sieczkarek

Overview

Mark Sieczkarek received an average of $1M in total compensation, including $268K in salary, at NovaBay Pharmaceuticals from 2015 to 2018.

Source: SEC filings on April 19, 2019, April 18, 2018, and April 21, 2017.

Related executives

We found 11 more executives who work or worked at NovaBay Pharmaceuticals.

Justin Hall

NovaBay Pharmaceuticals

Chief Executive Officer

Andrew Jones

NovaBay Pharmaceuticals

Chief Financial Officer

Wang Xu

NovaBay Pharmaceuticals

Senior Manager and Controller

Jason Raleigh

NovaBay Pharmaceuticals

Chief Financial Officer

John McGovern

NovaBay Pharmaceuticals

Chief Executive Officer

Lewis Stuart

NovaBay Pharmaceuticals

Former Chief Commercial Officer

Thomas Paulson

NovaBay Pharmaceuticals

Chief Financial Officer

Ramin Najafi

NovaBay Pharmaceuticals

Chief Executive Officer

News

You may also like